Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 196.08

-0.2%

Jan 15 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (12862)	12/28/1997 11:37:00 PM
From: Scusami	Read Replies (1) of 32384

Andy: Here's another comment I received via email: Biotechs to Watch George Stasen Just because a stock's price has fallen is no reason to avoid the company-- or to buy it. Technology stock analyst George Stasen thinks investors interested in biotechnology companies need to learn how to find value, irrespective of the share price. "Today's depressed prices (in biotechs) are (no) more indicative of inherent value than the peak prices registered during the past year," he says. Stasen's a proponent of research, especially on those companies whose stock may have dropped 50%. The latest online column from this co-author of the Wall Street primer, It's a Sure Thing, offers five companies he believes have considerable potential. They are Cambridge Neuroscience (CNSI:Nasdaq), Cytel (CYTL:Nasdaq), Interneuron Pharmaceuticals (IPIC:Nasdaq), NABI (NABI:Nasdaq) and Regeneron Pharmaceuticals (REGN:Nasdaq). "Strip off the unpleasant wrapping of past price action, and hunt for your generous gift under the Christmas tree," Stasen advises. * More information can be found at: talks.com Scusami

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next